Product logins

Find logins to all Clarivate products below.


Facial Injectables | Asia Pacific | 2014 | Market Analysis

Valued at $588 million in 2013, the Asia Pacific market for facial injectables will be among the most rapidly growing global markets over the next ten years, expanding to reach a value of over $1.8 billion by 2022.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for facial injectables (including botulinum toxins and dermal fillers) in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Trauma Devices – Market Insights – Asia Pacific
The Asia Pacific trauma device market is experiencing steady growth driven by a rising incidence of fractures, an aging population, and increasing rates of road traffic accidents, particularly in…
Report
Physician-Dispensed Cosmeceuticals – Market Insights – Europe
The European physician-dispensed cosmeceutical market will be driven by rising aesthetic consciousness, an aging population, and increasing demand for clinically validated skincare solutions. The…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…